Diverse pathomechanisms leading to the breakdown of cellular estrogen surveillance and breast cancer development: new therapeutic strategies

References

• Dorgan JF Longcope C Stephenson HEJr Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk Cancer Epidemiol Biomarkers Prev 1996 5 7 533 539 8827358
   PubMed Web of Science ®Google Scholar
• Cauley JA Lucas FL Kuller LH Stone K Browner W Cummings SR Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group Ann Intern Med 1999 130 4 Pt 1 270 277 10068384
   PubMed Web of Science ®Google Scholar
• The Endogenous Hormones and Breast Cancer Collaborative Group Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J Natl Cancer Inst 2002 94 8 606 616 11959894
   PubMedGoogle Scholar
• Endogenous Hormones and Breast Cancer Collaborative Group Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies Lancet Oncol 2013 14 10 1009 1019 23890780
   PubMed Web of Science ®Google Scholar
• Kaaks R Berrino F Key T Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC) J Natl Cancer Inst 2005 97 10 755 765 15900045
   PubMed Web of Science ®Google Scholar
• Fortner RT Eliassen AH Spiegelman D Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses’ Health Study II Breast Cancer Res 2013 15 2 R19 23497468
   PubMed Web of Science ®Google Scholar
• Zeleniuch-Jacquotte A Afanasyeva Y Kaaks R Premenopausal serum androgens and breast cancer risk: a nested case-control study Breast Cancer Res 2012 14 1 R32 22339988
   PubMed Web of Science ®Google Scholar
• Micheli A Muti P Secreto G Endogenous sex hormones and subsequent breast cancer in premenopausal women Int J Cancer 2004 112 2 312 318 15352045
   PubMed Web of Science ®Google Scholar
• Schernhammer ES Sperati F Razavi P Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort Breast Cancer Res 2013 15 R46 23777922
   PubMed Web of Science ®Google Scholar
• Eliassen AH Missmer SA Tworoger SS Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women J Natl Cancer Inst 2006 98 19 1406 1415 17018787
   PubMed Web of Science ®Google Scholar
• Walker K Bratton DJ Frost C Premenopausal endogenous oestrogen levels and breast cancer risk: a meta-analysis Br J Cancer 2011 105 9 1451 1457 21915119
   PubMed Web of Science ®Google Scholar
• James RE Lukanova A Dossus L Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study Cancer Prev Res (Phila) 2011 4 10 1626 1635 21813404
   PubMed Web of Science ®Google Scholar
• Zhang X Tworoger SS Eliassen AH Hankinson SE Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up Breast Cancer Res Treat 2013 137 3 883 892 23283524
   PubMed Web of Science ®Google Scholar
• Farhat GN Cummings SR Chlebowski RT Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers J Natl Cancer Inst 2011 103 7 562 570 21330633
   PubMedGoogle Scholar
• Schoemaker MJ Folkerd EJ Jones ME Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study Br J Cancer 2014 110 1898 1907 24518596
   PubMed Web of Science ®Google Scholar
• Zeleniuch-Jacquotte A Shore RE Koenig KL Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study Br J Cancer 2004 90 1 153 159 14710223
   PubMed Web of Science ®Google Scholar
• Baglietto L Severi G English DR Circulating steroid hormone levels and risk of breast cancer for postmenopausal women Cancer Epidemiol Biomarkers Prev 2010 19 2 492 502 20086116
   PubMed Web of Science ®Google Scholar
• Manjer J Johansson R Berglund G Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden) Cancer Causes Control 2003 14 7 599 607 14575357
   PubMed Web of Science ®Google Scholar
• Hankinson SE Willett WC Manson JE Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women J Natl Cancer Inst 1998 90 17 1292 1299 9731736
   PubMedGoogle Scholar
• Missmer SA Eliassen AH Barbieri RL Hankinson SE Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women J Natl Cancer Inst 2004 96 24 1856 1865 15601642
   PubMedGoogle Scholar
• Cummings SR Lee JS Lui LY Stone K Ljung BM Cauley JA Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study Cancer Epidemiol Biomarkers Prev 2005 14 5 1047 1051 15894651
   PubMed Web of Science ®Google Scholar
• Sieri S Krogh V Bolelli G Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort Cancer Epidemiol Biomarkers Prev 2009 18 1 169 176 19124495
   PubMed Web of Science ®Google Scholar
• Fuhrman BJ Schairer C Gail MH Estrogen metabolism and risk of breast cancer in postmenopausal women J Natl Cancer Inst 2012 104 4 326 339 22232133
   PubMedGoogle Scholar
• Sturgeon SR Potischman N Malone KE Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA) Cancer Causes Control 2004 15 1 45 53 14970734
   PubMed Web of Science ®Google Scholar
• Endogenous Hormones and Breast Cancer Collaborative Group Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies Br J Cancer 2011 105 709 722 21772329
   PubMed Web of Science ®Google Scholar
• Falk RT Brinton LA Dorgan JF Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study Breast Cancer Res 2013 15 2 R34 23607871
   PubMed Web of Science ®Google Scholar
• Lamar CA Dorgan JF Longcope C Stanczyk FZ Falk RT Stephenson HEJr Serum sex hormones and breast cancer risk factors in postmenopausal women Cancer Epidemiol Biomarkers Prev 2003 12 4 380 833 12692114
   PubMed Web of Science ®Google Scholar
• Björnström L Sjöberg M Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes Mol Endocrinol 2005 19 4 833 842 15695368
   PubMedGoogle Scholar
• Ascenzi P Bocedi A Marino M Structure-function relationship of estrogen receptor alpha and beta: impact on human health Mol Aspects Med 2006 27 4 299 402 16914190
   PubMedGoogle Scholar
• Levin ER Integration of the extranuclear and nuclear actions of estrogen Mol Endocrinol 2005 19 8 1951 1959 15705661
   PubMedGoogle Scholar
• Suba Z Common soil of smoking-associated and hormone-related cancers: estrogen deficiency Oncol Rev 2010 4 2 73 87
   Google Scholar
• Suba Z Low estrogen exposure and/or defective estrogen signaling induces disturbances in glucose uptake and energy expenditure J Diabetes Metab 2013 4 272
   Google Scholar
• Smith CL Cross-talk between peptide growth factor and estrogen receptor signaling pathways Biol Reprod 1998 58 3 627 632 9510949
   PubMed Web of Science ®Google Scholar
• Smith EP Boyd J Frank GR Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man N Engl J Med 1994 331 1056 1061 8090165
   PubMed Web of Science ®Google Scholar
• Quaynor SD Stradtman EW Kim HG Delayed puberty and estrogen resistance in a woman with estrogen receptor α variant N Engl J Med 2013 369 2 164 171 23841731
   PubMed Web of Science ®Google Scholar
• Barros RP Machado UF Gustafsson JA Estrogen receptors: new players in diabetes mellitus Trends Mol Med 2006 12 9 425 431 16890492
   PubMed Web of Science ®Google Scholar
• Barros RP Gustafsson JÅ Estrogen receptors and the metabolic network Cell Metab 2011 14 3 289 299 21907136
   PubMed Web of Science ®Google Scholar
• Morishima A Grumbach MM Simpson ER Fisher C Qin K Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens J Clin Endocrinol Metab 1995 80 12 3689 3698 8530621
   PubMed Web of Science ®Google Scholar
• Simpson ER Sources of estrogen and their importance J Steroid Biochem Mol Biol 2003 86 3–5 225 230 14623515
   PubMed Web of Science ®Google Scholar
• Maffei L Rochira V Zirilli L A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome Clin Endocrinol (Oxf) 2007 67 2 218 224 17547681
   PubMed Web of Science ®Google Scholar
• Spangenburg EE Wohlers LM Valencia AP Metabolic dysfunction under reduced estrogen levels: looking to exercise for prevention Exerc Sport Sci Rev 2012 40 4 195 203 22653278
   PubMed Web of Science ®Google Scholar
• Faulds MH Zhao C Dahlman-Wright K Gustaffson J The diversity of sex steroid action: regulation of metabolism by estrogen signaling J Endocrinol 2012 212 3 12 21511884
   PubMed Web of Science ®Google Scholar
• Suba Z Interplay between insulin resistance and estrogen deficiency as co-activators in carcinogenesis Pathol Oncol Res 2012 18 2 123 133 21984197
   PubMed Web of Science ®Google Scholar
• Suba Z Circulatory estrogen level protects against breast cancer in obese women Recent Pat Anticancer Drug Discov 2013 8 2 154 167 23061769
   PubMed Web of Science ®Google Scholar
• Stamataki KE Spina J Rangou DB Chlouverakis CS Piaditis GP Ovarian function in women with non-insulin dependent diabetes mellitus Clin Endocrinol (Oxf) 1996 45 5 615 621 8977760
   PubMed Web of Science ®Google Scholar
• Vriend J Bertalanffy FD Ralcewicz TA The effects of melatonin and hypothyroidism on estradiol and gonadotropin levels in female Syrian hamsters Biol Reprod 1987 36 719 728 3109508
   PubMed Web of Science ®Google Scholar
• Suba Z Light deficiency confers breast cancer risk by endocrine disorders Recent Pat Anticancer Drug Discov 2012 7 3 337 344 22694289
   PubMed Web of Science ®Google Scholar
• Nestler JE Obesity, insulin, sex steroids and ovulation Int J Obes Relat Metab Disord 2000 24 Suppl 2 S71 S73 10997613
   PubMed Web of Science ®Google Scholar
• Björntorp P The regulation of adipose tissue distribution in humans Int J Obes Relat Metab Disord 1996 20 4 291 302 8680455
   PubMed Web of Science ®Google Scholar
• Christakou CD Diamanti-Kandarakis E Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome Womens Health (Lond Engl) 2008 4 6 583 594 19072461
   PubMedGoogle Scholar
• Attia GR Rainey WE Carr BR Metformin directly inhibits androgen production in human thecal cells Fertil Steril 2001 76 3 517 524 11532475
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E Baillargeon JP Iuorno MJ Jakubowicz DJ Nestler JE A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills J Clin Endocrinol Metab 2003 88 5 1927 1932 12727935
   PubMed Web of Science ®Google Scholar
• Lindberg BS Johansson ED Nilsson BA Plasma levels of nonconjugated oestrone, oestradiol–17beta and oestriol during uncomplicated pregnancy Acta Obstet Gynecol Scand Suppl 1974 2 21 36 4527049
   PubMedGoogle Scholar
• Key TJ Hormones and cancer in humans Mutat Res 1995 333 1–2 59 67 8538637
   PubMed Web of Science ®Google Scholar
• Britt K Ashworth A Smalley M Pregnancy and the risk of breast cancer Endocr Relat Cancer 2007 14 4 907 933 18045947
   PubMed Web of Science ®Google Scholar
• Maggi A Liganded and unliganded activation of estrogen receptor and hormone replacement therapies Biochim Biophys Acta 2011 1812 8 1054 1060 21605666
   PubMed Web of Science ®Google Scholar
• Jordan VC Ford LG Paradoxical clinical effect of estrogen on breast cancer risk: a “new” biology of estrogen-induced apoptosis Cancer Prev Res (Phila) 2011 4 5 633 637 21478501
   PubMed Web of Science ®Google Scholar
• Suba Z Failures and controversies of the antiestrogen treatment of breast cancer Suba Z Estrogen Prevention for Breast Cancer New York, NY Nova Science Publishers Inc 2013 105 125
   Google Scholar
• Widschwendter M Rosenthal AN Philpott S The sex hormone system in carriers of BRCA1/2 mutations: a case-control study Lancet Oncol 2013 14 12 1226 1232 24140203
   PubMed Web of Science ®Google Scholar
• Kim J Oktay K Baseline E(2) levels are higher in BRCA2 mutation carriers: a potential target for prevention? Cancer Causes Control 2013 24 3 421 426 23271408
   PubMed Web of Science ®Google Scholar
• Suba Z Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implications Onco Targets Ther 2014 7 147 164 24482576
   PubMed Web of Science ®Google Scholar
• Oktay K Kim JY Barad D Babayev SN Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks J Clin Oncol 2010 28 2 240 244 19996028
   PubMed Web of Science ®Google Scholar
• Finch A Valentini A Greenblatt E Hereditary Breast Cancer Study Group Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation Fertil Steril 2013 99 6 1724 1728 23414920
   PubMed Web of Science ®Google Scholar
• Lin WT Beattie M Chen LM Comparison of age at natural menopause in BRCA 1/2 mutation carriers with a non-clinic-based sample of women in northern California Cancer 2013 119 9 1652 1659 23362014
   PubMed Web of Science ®Google Scholar
• Bordeleau L Lipscombe L Lubinski J Hereditary Breast Cancer Clinical Study Group Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations Cancer 2011 117 9 1812 1818 21509758
   PubMed Web of Science ®Google Scholar
• Wang KC Woung LC Tsai MT Liu CC Su YH Li CY Risk of alzheimer’s disease in relation to diabetes: a population-based cohort study Neuroepidemiology 2012 38 237 244 22572745
   PubMed Web of Science ®Google Scholar
• Carcaillon L Brailly-Tabard S Ancelin ML High plasma estradiol interacts with diabetes on risk of dementia in older postmenopausal women Neurology 2014 82 6 504 511 24477111
   PubMed Web of Science ®Google Scholar
• Wu SI Chou P Tsai ST The impact of years since menopause on the development of impaired glucose tolerance J Clin Epidemiol 2001 54 2 117 120 11166525
   PubMed Web of Science ®Google Scholar
• Onland-Moret NC van Gils CH Roest M Grobbee DE Peeters PH The estrogen receptor alpha gene and breast cancer risk (the Netherlands) Cancer Causes Control 2005 16 10 1195 1202 16215870
   PubMed Web of Science ®Google Scholar
• Herynk MH Fuqua SA Estrogen receptor mutations in human disease Endocr Rev 2004 25 6 869 898 15583021
   PubMed Web of Science ®Google Scholar
• Shin A Kang D Nishio H Estrogen receptor alpha gene polymorphisms and breast cancer risk Breast Cancer Res Treat 2003 80 127 131 12889606
   PubMed Web of Science ®Google Scholar
• Cai Q Shu XO Jin F Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study Cancer Epidemiol Biomarkers Prev 2003 12 853 859 14504194
   PubMed Web of Science ®Google Scholar
• Zheng SL Zheng W Chang BL Joint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women Cancer Res 2003 63 22 7624 7629 14633679
   PubMed Web of Science ®Google Scholar
• Ryan J Canonico M Carcaillon L Hormone treatment, estrogen receptor polymorphisms and mortality: a prospective cohort study PLoS One 2012 7 e34112 22457817
   PubMed Web of Science ®Google Scholar
• Bloomgarden ZT Second World Congress on the Insulin Resistance Syndrome: mediators, pediatric insulin resistance, the polycystic ovary syndrome, and malignancy Diabetes Care 2005 28 8 1821 1830 15983348
   PubMed Web of Science ®Google Scholar
• Suba Z Ujpál M Correlations of insulin resistance and neoplasms Magy Onkol 2006 50 2 127 135 Hungarian 16888676
   PubMedGoogle Scholar
• Reaven GM Banting lecture 1988: role of insulin resistance in human disease Diabetes 1988 37 12 1595 1607 3056758
   PubMed Web of Science ®Google Scholar
• Gupta K Krishnaswamy G Karnad A Peiris A Insulin: a novel factor in carcinogenesis Am J Med Sci 2002 323 3 140 145 11908858
   PubMed Web of Science ®Google Scholar
• Yu H Rohan T Role of insulin-like growth factor family in cancer development and progression J Natl Cancer Inst 2000 92 18 1472 1489 10995803
   PubMed Web of Science ®Google Scholar
• Sartor BM Dickey RP Polycystic ovarian syndrome and the metabolic syndrome Am J Med Sci 2005 330 6 336 342 16355019
   PubMed Web of Science ®Google Scholar
• Moghetti P Castello R Negri C Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17, 20-lyase activity J Clin Endocrinol Metab 1996 81 3 881 886 8772544
   PubMed Web of Science ®Google Scholar
• Cara JF Rosenfield RL Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells Endocrinology 1988 123 2 733 739 2969325
   PubMed Web of Science ®Google Scholar
• Shupnik MA Gordon MS Chin WW Tissue-specific regulation of rat estrogen receptor mRNAs Mol Endocrinol 1989 3 4 660 665 2725529
   PubMedGoogle Scholar
• Pascall JC Post-transcriptional regulation of gene expression by androgens: recent observations from the epidermal growth factor gene J Mol Endocrinol 1997 18 177 180 9195471
   PubMed Web of Science ®Google Scholar
• Veldhuis JD Frystyk J Iranmanesh A Ørskov H Testosterone and estradiol regulate free insulin-like growth factor I (IGF-I), IGF binding protein 1 (IGFBP-1), and dimeric IGF-I/IGFBP-1 concentrations J Clin Endocrinol Metab 2005 90 5 2941 2947 15713723
   PubMed Web of Science ®Google Scholar
• Lukanova A Lundin E Zeleniuch-Jacquotte A Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women Eur J Endocrinol 2004 150 2 161 171 14763914
   PubMed Web of Science ®Google Scholar
• Stoica A Saceda M Doraiswamy VL Coleman C Martin MB Regulation of estrogen receptor-alpha gene expression by epidermal growth factor J Endocrinol 2000 165 2 371 378 10810301
   PubMed Web of Science ®Google Scholar
• Curtis SW Washburn T Sewall C Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor Proc Natl Acad Sci U S A 1996 93 22 12626 12630 8901633
   PubMed Web of Science ®Google Scholar
• Larsson SC Mantzoros CS Wolk A Diabetes mellitus and risk of breast cancer: a meta-analysis Int J Cancer 2007 121 4 856 862 17397032
   PubMed Web of Science ®Google Scholar
• Fan S Ma YX Wang C Role of direct interaction in BRCA1 inhibition of estrogen receptor activity Oncogene 2001 20 1 77 87 11244506
   PubMed Web of Science ®Google Scholar
• Zheng L Annab LA Afshari CA Lee WH Boyer TG BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor Proc Natl Acad Sci U S A 2001 98 17 9587 9592 11493692
   PubMed Web of Science ®Google Scholar